BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 7796406)

  • 1. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.
    Kunugi KA; Vazquez-Padua MA; Miller EM; Kinsella TJ
    Cancer Res; 1990 Aug; 50(16):4962-7. PubMed ID: 2199032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low pH does not affect the dose response for 5'-amino-5'-deoxythymidine modulation of IdUrd DNA incorporation and radiosensitization in a human bladder cancer cell line.
    Kunugi KA; Miller EM; Vazquez-Padua MA; Kinsella TJ
    Radiat Res; 1992 Nov; 132(2):222-7. PubMed ID: 1438704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bleomycin with iododeoxyuridine, 5'-amino-5'-deoxythymidine, and radiation in a human bladder cancer cell line.
    Kunugi KA; Lindstrom MJ; Kinsella TJ
    Radiat Res; 1993 Aug; 135(2):262-8. PubMed ID: 7690149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells.
    Chi KH; Kunugi KA; Kinsella TJ
    Cancer Res; 1994 May; 54(10):2701-6. PubMed ID: 8168100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of hydroxyurea and ionizing radiation in human cervical carcinoma cells.
    Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
    Cancer J Sci Am; 1997; 3(3):163-73. PubMed ID: 9161782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitization and cell kinetics: clinical implications for S-phase-specific radiosensitizers.
    Kinsella TJ
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):41-7. PubMed ID: 1641656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical rationale for S-phase radiosensitization in human tumors.
    McGinn CJ; Kinsella TJ
    Curr Probl Cancer; 1993; 17(5):273-321. PubMed ID: 8281809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiobiology and clinical application of halogenated pyrimidine radiosensitizers.
    Mitchell JB; Russo A; Cook JA; Straus KL; Glatstein E
    Int J Radiat Biol; 1989 Nov; 56(5):827-36. PubMed ID: 2573682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation.
    McGinn CJ; Kinsella TJ
    Semin Oncol; 1992 Aug; 19(4 Suppl 11):21-8. PubMed ID: 1509278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Animal Model for Assessing the Effects of Hydroxyurea Exposure Suggests That the Administration of This Agent to Pregnant Women and Young Infants May Not Be as Safe as We Thought.
    Rodríguez-Vázquez L; Martí J
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells.
    Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
    Cancer Res; 1995 Jul; 55(13):2800-5. PubMed ID: 7796406
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.